Cis-diamminedichloroplatinum (II) chemotherapy in advanced pancreatic carcinoma
Tajiri, H.; Yoshimori, M.; Hijikata, A.; Nakamura, K.; Ohkura, H.; Okazaki, N.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(11): 3101-3104
1987
ISSN/ISBN: 0385-0684 PMID: 3674895 Document Number: 297608
The effect of cis-diamminedichloro platinum (II) (CDDP) was evaluated in 14 patients with advanced pancreatic carcinoma. Prior chemotherapy was done in 7 cases and the remaining 7 were fresh cases. The drug was given at a dose of 80 mg/m2 I.V. every 3 weeks, with hydration and mannitol diuresis. Four cases out of 14 showed no change, while the remaining 10 cases showed progressive disease. The response rate was 0%. Most of the patients who showed myelosuppression had received prior chemotherapy. Non-hematologic toxicity occurred in 9 patients (64%) and consisted of nausea in 9, vomiting in 7 and anorexia in 9. Values of serum creatinine and BUN were transiently elevated.